Evidence map›Paper›PMID 20890109›Full record

ArticleCell cycle (Georgetown, Tex.)2010

Ku80 facilitates chromatin binding of the telomere binding protein, TRF2.

Lauren S Fink, Chad A Lerner, Paulina F Torres, Christian Sell

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lauren S FinkDrexel University College of Medicine, Department of Pathology and Laboratory Medicine, Philadelphia, Pennsylvania, USA.
Chad A Lerner
Paulina F Torres
Christian Sell
Drexel University · US

Funding

TRAINING PROGRAM IN CANCER RESEARCHT32CA009035 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 1985 to 2020
$10.5M
Role of IGF-1 in Modulation of LongevityR01AG022443 · NIA · LANKENAU INSTITUTE FOR MEDICAL RESEARCH · PI SELL, CHRISTIAN · 2005 to 2009
$1.7M
NCI NIH HHS T32 CA009035NIA NIH HHS AG022443NIA NIH HHS R01 AG022443
6 · The paper itself

Abstract

The Ku70/80 heterodimer is central to non-homologous end joining repair of DNA double-strand breaks and the Ku80 gene appears to be essential for human but not rodent cell survival. The Ku70/80 heterodimer is located at telomeres but its precise function in telomere maintenance is not known. In order to examine the role of Ku80 beyond DNA repair in more detail, we have taken a knockdown approach using a human fibroblast strain. Following targeted Ku80 knockdown, telomere defects are observed and the steady state levels of the TRF2 protein are reduced. Inhibitor studies indicate that this loss of TRF2 is mediated by the proteasome and degradation of TRF2 following Ku depletion appears to involve a decrease in chromatin binding of TRF2, suggesting that the Ku heterodimer enhances TRF2 chromatin association and that non-chromatin bound TRF2 is targeted to the proteasome.

Indexed as

Antigens, NuclearChromatinDimerizationDNA-Binding ProteinsFibroblastsHumansKu AutoantigenProteasome Endopeptidase ComplexProtein BindingRNA InterferenceTelomereTelomeric Repeat Binding Protein 2Antigens, NuclearChromatinDNA-Binding ProteinsKu AutoantigenProteasome Endopeptidase ComplexTelomeric Repeat Binding Protein 2Xrcc6 protein, human

Identifiers

PMID20890109
PMCPMC3047804
OpenAlexW2016626378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.